Cedar Brook Financial Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-766
| Closed | -$303K | – | 424 |
|
|
2024
Q1 | $303K | Hold |
766
| – | – | 0.06% | 311 |
|
|
2023
Q4 | $272K | Sell |
766
-16
| -2% | -$5.67K | 0.06% | 318 |
|
|
2023
Q3 | $293K | Hold |
782
| – | – | 0.08% | 260 |
|
|
2023
Q2 | $299K | Sell |
782
-13
| -2% | -$4.97K | 0.07% | 283 |
|
|
2023
Q1 | $275K | Buy |
+795
| New | +$275K | 0.07% | 280 |
|
|
2022
Q3 | – | Sell |
-801
| Closed | -$242K | – | 370 |
|
|
2022
Q2 | $242K | Sell |
801
-13
| -2% | -$3.93K | 0.08% | 288 |
|
|
2022
Q1 | $334K | Buy |
814
+9
| +1% | +$3.69K | 0.09% | 252 |
|
|
2021
Q4 | $378K | Sell |
805
-46
| -5% | -$21.6K | 0.1% | 226 |
|
|
2021
Q3 | $361K | Sell |
851
-23
| -3% | -$9.76K | 0.11% | 216 |
|
|
2021
Q2 | $314K | Hold |
874
| – | – | 0.09% | 258 |
|
|
2021
Q1 | $246K | Buy |
874
+12
| +1% | +$3.38K | 0.09% | 271 |
|
|
2020
Q4 | $244K | Sell |
862
-30
| -3% | -$8.49K | 0.09% | 264 |
|
|
2020
Q3 | $245K | Sell |
892
-24
| -3% | -$6.59K | 0.1% | 237 |
|
|
2020
Q2 | $208K | Buy |
+916
| New | +$208K | 0.09% | 253 |
|
|
2020
Q1 | – | Sell |
-2,058
| Closed | -$309K | – | 306 |
|
|
2019
Q4 | $309K | Buy |
2,058
+18
| +0.9% | +$2.7K | 0.13% | 198 |
|
|
2019
Q3 | $289K | Buy |
2,040
+8
| +0.4% | +$1.13K | 0.13% | 211 |
|
|
2019
Q2 | $254K | Hold |
2,032
| – | – | 0.12% | 238 |
|
|
2019
Q1 | $224K | Buy |
+2,032
| New | +$224K | 0.11% | 248 |
|